Mylan Announces Tentative Approval For Amlodipine Besylate And Benazepril Hydrochloride Capsules

... Mylan Laboratories Inc.(NYSE: MYL) today announced that the U.S. Food and Drug Administration hasgranted tentative approval for Mylan Pharmaceuticals Inc.'s Abbreviated NewDrug Application for Amlodipine Besylate and Benazepril HydrochlorideCapsules, 2.5 mg (base)/10 mg, 5 mg (base)/10 mg, 5 mg (base)/20 mg and 10 mg (base)/20 mg. [click link for full article] ...